XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.880
+0.020 (0.70%)
At close: Jun 6, 2025, 4:00 PM
2.900
+0.020 (0.69%)
After-hours: Jun 6, 2025, 4:04 PM EDT

XBiotech Statistics

Total Valuation

XBiotech has a market cap or net worth of $88.41 million. The enterprise value is -$67.48 million.

Market Cap 88.41M
Enterprise Value -67.48M

Important Dates

The last earnings date was Wednesday, May 14, 2025.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

XBiotech has 30.49 million shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class 30.49M
Shares Outstanding 30.49M
Shares Change (YoY) +0.11%
Shares Change (QoQ) +0.07%
Owned by Insiders (%) 34.88%
Owned by Institutions (%) 14.97%
Float 19.85M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.51
P/TBV Ratio 0.51
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 29.15

Current Ratio 29.15
Quick Ratio 28.93
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -64.99

Financial Efficiency

Return on equity (ROE) is -20.53% and return on invested capital (ROIC) is -14.33%.

Return on Equity (ROE) -20.53%
Return on Assets (ROA) -13.78%
Return on Invested Capital (ROIC) -14.33%
Return on Capital Employed (ROCE) -25.60%
Revenue Per Employee n/a
Profits Per Employee -$428,402
Employee Count 92
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -28,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -59.66% in the last 52 weeks. The beta is 0.97, so XBiotech's price volatility has been similar to the market average.

Beta (5Y) 0.97
52-Week Price Change -59.66%
50-Day Moving Average 2.98
200-Day Moving Average 4.89
Relative Strength Index (RSI) 48.55
Average Volume (20 Days) 42,873

Short Selling Information

The latest short interest is 806,134, so 2.64% of the outstanding shares have been sold short.

Short Interest 806,134
Short Previous Month 898,575
Short % of Shares Out 2.64%
Short % of Float 4.06%
Short Ratio (days to cover) 13.55

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -45.17M
Pretax Income -30.44M
Net Income -39.41M
EBITDA -43.41M
EBIT -45.17M
Earnings Per Share (EPS) -$1.29
Full Income Statement

Balance Sheet

The company has $155.90 million in cash and n/a in debt, giving a net cash position of $155.90 million or $5.11 per share.

Cash & Cash Equivalents 155.90M
Total Debt n/a
Net Cash 155.90M
Net Cash Per Share $5.11
Equity (Book Value) 174.71M
Book Value Per Share 5.73
Working Capital 152.28M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$30.48 million and capital expenditures -$1.14 million, giving a free cash flow of -$31.62 million.

Operating Cash Flow -30.48M
Capital Expenditures -1.14M
Free Cash Flow -31.62M
FCF Per Share -$1.04
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

XBiotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.11%
Shareholder Yield -0.11%
Earnings Yield -44.58%
FCF Yield -35.77%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2